Literature DB >> 3707116

In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.

W R Bowie.   

Abstract

In vitro, growth of Chlamydia trachomatis was not entirely eliminated by 960 micrograms of ticarcillin per ml, 64 micrograms of amoxicillin per ml, 32 micrograms of clavulanic acid per ml, a combination of ticarcillin (480 micrograms/ml) and clavulanic acid (32 micrograms/ml), and a combination of amoxicillin (32 micrograms/ml) and clavulanic acid (8 micrograms/ml). However, a greater than or equal to 99% decrease in the number of inclusions was obtained at concentrations readily attainable in serum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707116      PMCID: PMC180474          DOI: 10.1128/AAC.29.4.713

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

Authors:  C C Kuo; S P Wang; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

Review 2.  Salpingitis: overview of etiology and epidemiology.

Authors:  K K Holmes; D A Eschenbach; J S Knapp
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

3.  Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

4.  Eradication of Chlamydia trachomatis from the urethras of men with nongonococcal urethritis by treatment with amoxicillin.

Authors:  W R Bowie; E R Alexander; K K Holmes
Journal:  Sex Transm Dis       Date:  1981 Apr-Jun       Impact factor: 2.830

5.  Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.

Authors:  G Johannisson; A Sernryd; E Lycke
Journal:  Sex Transm Dis       Date:  1979 Apr-Jun       Impact factor: 2.830

6.  In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  M R Hammerschlag; A Gleyzer
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

7.  Synthesis of trachoma agent proteins in emetine-treated cells.

Authors:  Y Becker; Y Asher
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

8.  Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia.

Authors:  M J Kramer; F B Gordon
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

9.  Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.

Authors:  W R Bowie; C K Lee; E R Alexander
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

10.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  Br J Vener Dis       Date:  1978-04
View more
  10 in total

1.  In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  H Talbot; B Romanowski
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 2.  Antimicrobial chemotherapy of chlamydial infection: where next?

Authors:  G L Ridgway
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

3.  Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice.

Authors:  X X Bin; K Wolf; T Schaffner; R Malinverni
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 4.  Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

Authors:  C A Marra; D M Patrick; R Reynolds; F Marra
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

Review 5.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii.

Authors:  Alejandro Beceiro; Rafael López-Rojas; Juan Domínguez-Herrera; Fernando Docobo-Pérez; Germán Bou; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

7.  Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin.

Authors:  A S Beale; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice.

Authors:  R Phillips Campbell; J Kintner; J Whittimore; R V Schoborg
Journal:  Microbes Infect       Date:  2012-08-23       Impact factor: 2.700

9.  In Vitro Susceptibility Testing of Clinical Isolates of Chlamydia trachomatis.

Authors:  M G Martens; S Faro; M Maccato; G Riddle; H Hammill; Y Wang
Journal:  Infect Dis Obstet Gynecol       Date:  1993

10.  Treatment of cervical chlamydial infection with amoxicillin/clavulanate potassium.

Authors:  M S Mann; S Faro; M L Maccato; R H Kaufman
Journal:  Infect Dis Obstet Gynecol       Date:  1993
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.